Advertisement
Advertisement
U.S. Markets open in 7 hrs 53 mins
Advertisement
Advertisement
Advertisement
Advertisement

Goldman Sachs International Tax-Managed Equity Fund Class R6 (GHTRX)

Nasdaq - Nasdaq Delayed Price. Currency in USD
Add to watchlist
10.65+0.11 (+1.04%)
At close: 08:00PM EDT
Advertisement
Full screen
Previous Close10.54
YTD Return-16.11%
Expense Ratio (net)0.00%
CategoryForeign Large Blend
Last Cap Gain0.00
Morningstar Rating★★★★★
Morningstar Risk RatingAverage
Sustainability Rating
Net Assets791.14M
Beta (5Y Monthly)N/A
Yield3.26%
5y Average ReturnN/A
Holdings Turnover162.00%
Last Dividend0.00
Average for CategoryN/A
Inception DateApr 30, 2018
  • GlobeNewswire

    Galapagos creates new subscription right plans

    Mechelen, Belgium; 6 May 2022, 22.01 CET; regulated information –– Galapagos NV (Euronext & NASDAQ: GLPG) announced today that its board of directors created 2,326,025 subscription rights under new subscription right plans for the benefit of certain members of the personnel of the company and its subsidiaries. On 6 May 2022, the board of directors of Galapagos approved “Subscription Right Plan 2022 BE”, intended for members of personnel of the company and its Belgian subsidiary, “Subscription Ri

  • GlobeNewswire

    Galapagos demonstrates regulatory and commercial progress in Q1 2022

    First three months 2022 financial results: Jyseleca® net sales reached €14.4 millionGroup revenues +20% to €136.3 millionOperating loss -58% to €21.1 millionCash and current financial investments of €4.6 billion on 31 March 2022 Jyseleca approved in Great Britain and Japan for the treatment of ulcerative colitis (UC); commercial roll-out in the EU in rheumatoid arthritis (RA) and UC progressing well with 15 countries reimbursed for RADr. Paul Stoffelsi appointed as Chief Executive Officer (CEO),

Advertisement
Advertisement